Draft report on the development of a harmonised approach to exposure assessment methodologies for residues from veterinary medicinal products, feed additives and pesticides in food of animal origin

July 5, 2022

Tractor spraying a field of crops.

In 2020, the European Commission (EC) requested EMA and European Food Safety Authority (EFSA) for advice for the development of a harmonised approach on exposure assessment methodologies for residues from veterinary medicinal products (EMA), feed additives and pesticides in food of animal origin (EFSA). This work was undertaken under the EC mandate by a working group composed of CVMP experts, EFSA experts, specialists with expertise from the Joint FAO / WHO Expert Committee on Food Additives (JECFA) and the Joint Meeting on Pesticide Residues (JMPR), and an European Chemichal Agency (ECHA) observer. The draft report compares available models of consumer exposure and makes recommendation on a harmonised approach to be used by EMA and EFSA for the assessment of exposure to residues of veterinary medicines, feed additives and pesticides in food of animal origin.

Download the Draft Report

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs

TAGS:

August 28, 2015

FDA Extends Comment Period For Its “Request for Quality Metrics” Draft Guidance

Last month, FDA published a draft guidance titled “Request for Quality Metrics,” which outlined the ways in which it intends to collect and use quality metrics. The guidance states that the data will...

August 31, 2015

Report Says FDA Significantly Reduced Medical Device Review Times

Earlier this year, FDA published a report announcing that the Agency’s device program has shown “a pattern of markedly improved performance.” Over the past five years, FDA has been working to improve...

February 28, 2019

Draft Guidance: Requesting Nonbinding Feedback After an FDA Inspection of Your Medical Device Establishment

On Tuesday, February 19th, FDA published a draft guidance for medical device makers which identifies a process for companies to request nonbinding feedback on certain FDA Form 483 deficiencies noted...